AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,234 | +50.2% | 5,145 | +38.7% | 0.01% | +42.9% |
| Q2 2023 | $173,220 | +62.3% | 3,710 | +33.0% | 0.01% | +75.0% |
| Q1 2023 | $106,745 | -18.6% | 2,790 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $131,130 | +92.8% | 2,790 | +38.4% | 0.01% | +66.7% |
| Q3 2022 | $68,000 | +257.9% | 2,016 | 0.0% | 0.00% | +200.0% |
| Q2 2022 | $19,000 | -34.5% | 2,016 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $29,000 | -32.6% | 2,016 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $43,000 | -4.4% | 2,016 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $45,000 | -10.0% | 2,016 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $50,000 | +78.6% | 2,016 | +107.8% | 0.00% | +100.0% |
| Q1 2021 | $28,000 | +12.0% | 970 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $25,000 | -16.7% | 970 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $30,000 | +66.7% | 970 | +32.9% | 0.00% | 0.0% |
| Q2 2020 | $18,000 | +125.0% | 730 | +82.5% | 0.00% | – |
| Q1 2020 | $8,000 | -11.1% | 400 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |